European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma-Reference-Cited by-同舟云学术

European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma

Published:2019-06-29 Issue:10 Volume:46 Page:2112-2137
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Taïeb David,Hicks Rodney J.,Hindié Elif,Guillet Benjamin A.,Avram Anca,Ghedini Pietro,Timmers Henri J.,Scott Aaron T.,Elojeimy Saeed,Rubello Domenico,Virgolini Irène J.,Fanti Stefano,Balogova Sona,Pandit-Taskar Neeta,Pacak Karel

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-019-04398-1.pdf

Reference168 articles.

1. Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99:1915–42.

2. Lloyd RV, Osamura RY, Kloppel G, Rosai JWHO. Classification of Tumours of Endocrine Organs. Lyon: IARC Press; 2017.

3. Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, et al. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumours. Eur J Endocrinol. 2016;175:G1–G34.

4. Crona J, Taieb D, Pacak K. New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification. Endocr Rev. 2017;38:489–515.

5. Jafri M, Whitworth J, Rattenberry E, Vialard L, Kilby G, Kumar AV, et al. Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma. Clin Endocrinol. 2013;78:898–906.

Cited by 249 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pheochromocytoma. Preoperative approach;Medicina Clínica (English Edition);2024-09

2. Head and neck paragangliomas: recent advances in translational and clinical research and guidelines for patient care;Best Practice & Research Clinical Endocrinology & Metabolism;2024-09

3. Overview of recent guidelines and consensus statements on initial screening and management of phaeochromocytoma and paraganglioma in SDHx pathogenic variant carriers and patients;Best Practice & Research Clinical Endocrinology & Metabolism;2024-09

4. Prevention and management of hypertensive crises in children with pheochromocytoma and paraganglioma;Frontiers in Endocrinology;2024-08-20

5. International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents;Nature Reviews Endocrinology;2024-08-15